BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2343159)

  • 21. Cervical dysplasia in a large, predominantly black practice as diagnosed by colposcopy in patients with normal and class II Papanicolaou smears.
    Kioko GM
    J Reprod Med; 1979 Apr; 22(4):222-4. PubMed ID: 458768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland].
    Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A
    Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving compliance among women with abnormal Papanicolaou smears.
    Paskett ED; Phillips KC; Miller ME
    Obstet Gynecol; 1995 Sep; 86(3):353-9. PubMed ID: 7651642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
    JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Papanicolaou smear return in a hospital-based adolescent and young adult clinic.
    Kahn JA; Goodman E; Huang B; Slap GB; Emans SJ
    Obstet Gynecol; 2003 Mar; 101(3):490-9. PubMed ID: 12636952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cervical intraepithelial neoplasia diagnosis: emotional impact and nursing implications.
    Ferreira SE
    Clin Excell Nurse Pract; 1998 Jul; 2(4):218-24. PubMed ID: 10455565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of immediate and deferred colposcopy in a cervical screening program.
    Parham GP; Andrews NR; Lee ML
    Obstet Gynecol; 2000 Mar; 95(3):340-4. PubMed ID: 10711540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of knowledge and perception of the risk of cervical cancer on screening behavior in mainland Chinese women.
    Gu C; Chan CW; Twinn S; Choi KC
    Psychooncology; 2012 Dec; 21(12):1299-308. PubMed ID: 23208838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A cost-benefit analysis of colposcopy for cervical squamous intraepithelial lesions found on Papanicolaou smear.
    Chesebro MJ; Everett WD
    Arch Fam Med; 1996; 5(10):576-81. PubMed ID: 8930229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychosocial barriers to follow-up adherence after an abnormal cervical cytology test result among low-income, inner-city women.
    Hui SK; Miller SM; Wen KY; Fang Z; Li T; Buzaglo J; Hernandez E
    J Prim Care Community Health; 2014 Oct; 5(4):234-41. PubMed ID: 24718518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does knowledge influence pap test screening among young African-American women?
    Bynum SA; Guillaume DA; Brandt HM; Fletcher FE
    J Cancer Educ; 2014 Sep; 29(3):478-81. PubMed ID: 24488589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colposcopy for cervical squamous intraepithelial lesions found on Papanicolaou smear.
    Reed BD
    Arch Fam Med; 1996; 5(10):582-4. PubMed ID: 8930230
    [No Abstract]   [Full Text] [Related]  

  • 33. Perceptions of barriers and facilitators to cervical cancer screening among low-income, HIV-infected women from an integrated HIV clinic.
    Fletcher FE; Buchberg M; Schover LR; Basen-Engquist K; Kempf MC; Arduino RC; Vidrine DJ
    AIDS Care; 2014; 26(10):1229-35. PubMed ID: 24635664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Personal influencing factors associated with pap smear testing and cervical cancer.
    Ackerson K; Pohl J; Low LK
    Policy Polit Nurs Pract; 2008 Feb; 9(1):50-60. PubMed ID: 18492942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perceptions of cervical cancer and Pap smear screening behavior by women's sexual orientation.
    Price JH; Easton AN; Telljohann SK; Wallace PB
    J Community Health; 1996 Apr; 21(2):89-105. PubMed ID: 8728358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Papanicolaou testing: when does more become less?
    Sawaya GF
    Am J Med; 2005 Feb; 118(2):159-60. PubMed ID: 15694901
    [No Abstract]   [Full Text] [Related]  

  • 37. Family history of cancer predicts Papanicolaou screening behavior for African American and white women.
    Williams KP; Reiter P; Mabiso A; Maurer J; Paskett E
    Cancer; 2009 Jan; 115(1):179-89. PubMed ID: 19025974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow-up of abnormal Papanicolaou smears in a hospital-based adolescent clinic.
    Lavin C; Goodman E; Perlman S; Kelly LS; Emans SJ
    J Pediatr Adolesc Gynecol; 1997 Aug; 10(3):141-5. PubMed ID: 9288658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of interventions to improve follow-up after abnormal cervical cancer screening.
    Yabroff KR; Kerner JF; Mandelblatt JS
    Prev Med; 2000 Oct; 31(4):429-39. PubMed ID: 11006069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does the system of Papanicolaou test nomenclature affect the rate of referral for colposcopy? A survey of family physicians.
    Melnikow J; Sierk A; Flocke S; Peters CA
    Arch Fam Med; 1993 Mar; 2(3):253-8. PubMed ID: 8252144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.